Organization · Family Office
Elevat3 Capital
Elevat3 Capital is the venture capital arm of Christian Angermayer's family office, Apeiron Investment Group, focusing on high-growth technology companies in Europe and selectively in North America and Asia.
Overview
What Elevat3 Capital does
What Elevat3 Capital is
Elevat3 Capital is the venture capital arm of Christian Angermayer's family office, Apeiron Investment Group, focusing on high-growth technology companies in Europe and selectively in North America and Asia.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Elevat3 Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Elevat3 Capital as a funder
Investment thesis
Elevat3 Capital invests in high-growth technology companies undergoing significant transformation. The firm emphasizes innovative technologies in sectors like Life Sciences, FinTech, and food production.
Focus narrative
Elevat3 Capital invests in industries undergoing significant transformation, including Life Sciences, FinTech & Crypto, Future Tech, and the food industry. The firm typically leads or co-leads investments with ticket sizes ranging from $5 million to $20 million. Their investment strategy emphasizes high-growth opportunities that leverage innovative technologies, particularly in decentralized finance, real estate, food production, and health improvement.
Value beyond capital
Elevat3 Capital aims to add value beyond capital by influencing key factors that can enhance the valuation of its portfolio companies.
Terms and economics
- Typical check
- $5,000,000–$20,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Regions
- AsiaEuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 100
Portfolio context
Elevat3 Capital's portfolio includes over 100 high-growth tech companies. Notable portfolio companies include: AmyriAD Therapeutics BV: A biotech company focused on developing advanced treatments for Alzheimer's Disease, currently in Phase 3 clinical trials. Formo: A food biotech company creating sustainable dairy products using precision fermentation. GROPYUS: A PropTech company that digitalizes the housing market, offering affordable and sustainable living solutions. Neodigital Versicherung AG: A digital insurer providing comprehensive digitalization for B2B insurance services. Periskop Partners: A real estate investment platform focused on sustainable and impact-oriented projects across Europe. Tiakis Biotech AG: A biotech firm developing therapeutic solutions for high unmet medical needs, including treatments for postoperative complications and COVID-19.
Common questions
What to know about Elevat3 Capital
Upseed classifies Elevat3 Capital under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.